Latest filing published 13 Jun 2025 for OCULAR THERAPEUTIX, INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Leslie J. Williams (board member) discloses dealings in 2 companies, chiefly Ocular Therapeutix, Inc and Windtree Therapeutics Inc. In total, 7 filings cover trades dated from 14 June 2019 to 11 June 2025.
On the market, this insider has only ever bought: 1 purchase, €18k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants.
The record was last updated on 13 June 2025 with a share grant in Ocular Therapeutix, Inc. The most recent open-market purchase was published on 17 June 2019, 2,686 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations